Zachary M Avigan

10PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy.

|Jul 08, 2026
Belantamab mafodotin, a BCMA-directed antibody-drug conjugate for multiple myeloma.

|Aug 13, 2025
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy.

Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar

|Feb 09, 2025
An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myeloma.

Zachary M Avigan, Mohammad A Rattu, Joshua Richter

|Jul 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.

Zachary M Avigan, Suzanne Arinsburg, Darren Pan

|May 01, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.

Zachary M Avigan, Ajoy L Dias, Laura E Dodge

Pageof 2

Frequent Collaborators

4 joint publications

Joshua Richter

3 joint publications

Sundar Jagannath

2 joint publications

Adolfo Aleman

2 joint publications

Samir Parekh